If a biotech food product, like sugar beets in the example provided, is deemed by the FDA to be safe for human consumption, meet the same quality standards as a non-biotech, and is nutritionally and essentially the same as a non-biotech counterpart, should it be regulated by the FDA any differently?
Senator Daines questions the need for different regulations for biotech foods.
Share
More from Steve Daines
This was the first step to an important next step, which will be a meeting between President Xi and President Trump.
I will say I am disappointed that my Crow Revenue Act was not included in today's hearing.
What the president made clear is [he] does not want to see any cuts to beneficiaries.
This is a major victory for President Trump, the United States and most importantly, Marc Fogel and his family.
Other voices in this conversation
